FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2916787029> ?p ?o ?g. }

• W2916787029 abstract "Background: Currently, although non-steroidal anti-inflammatory drugs (NSAIDs) were recommended for acute renal colic in the 2018 European Association of Urology guidelines, there are no specific NSAIDs and no specific routes of administration in this guideline. The clinical practice of advocating intravenous opioids as the initial analgesia is still common out of the fear of adverse events from NSAIDs. Objectives: To comprehensively assess the efficacy and safety of NSAIDs, opioids, paracetamol, and combination therapy for acute renal colic. Methods: Ovid MEDLINE, Ovid EMbase, the Cochrane Library, Clinical Trials Registry Platform for Clinicaltrials.gov, and WHO International Clinical Trials Registry Platform were searched through February 2, 2018. Two reviewers selected all randomized controlled trails (RCTs) regarding NSAIDs, opioids, paracetamol, combination therapy, and placebo were identified for analysis. We designed a three-stage strategy based on classification and pharmacological mechanisms in the first stage, routes of administration in the second stage, and specific drug branches with different routes in the third stage using network meta-analysis. The pain variance at 30 min was seen as the primary outcome. Results: 65 RCTs with 8633 participants were involved. Comparing different classification and pharmacological mechanisms, combination therapy with more adverse events was more efficient than NSAIDs for the primary outcomes. Opioids gave rise to more nonspecific adverse events and vomiting events. NSAIDs were superior to opioids, paracetamol, and combination therapy after a full consideration of all outcomes. Comparing different routes of administration, NSAIDs with IV or IM route ranked first from efficacy and safety perspective. Comparing different specific drug branches with different routes, ibuprofen via IV route, ketorolac via IV route and diclofenac via IM route were superior for the management of acute renal colic. The results from diclofenac using IM route were more than those from ibuprofen used with IV route and ketorolac with IV route. Conclusions: In patients with adequate renal function, diclofenac via the IM route is recommended for patients without risks of cardiovascular events. Ibuprofen and ketorolac with IV route potentially superior to diclofenac via IM route remain to be investigated. Combination therapy is an alternative choice for uncontrolled pain after the use of NSAIDs." @default.
• W2916787029 created "2019-03-02" @default.
• W2916787029 creator A5005368388 @default.
• W2916787029 creator A5046904449 @default.
• W2916787029 creator A5060184027 @default.
• W2916787029 creator A5064286400 @default.
• W2916787029 creator A5066336201 @default.
• W2916787029 creator A5083278883 @default.
• W2916787029 date "2019-02-22" @default.
• W2916787029 modified "2023-10-13" @default.
• W2916787029 title "Increasing Nonsteroidal Anti-inflammatory Drugs and Reducing Opioids or Paracetamol in the Management of Acute Renal Colic: Based on Three-Stage Study Design of Network Meta-Analysis of Randomized Controlled Trials" @default.
• W2916787029 cites W1482870144 @default.
• W2916787029 cites W1496431016 @default.
• W2916787029 cites W1520369097 @default.
• W2916787029 cites W1539494216 @default.
• W2916787029 cites W1552630832 @default.
• W2916787029 cites W1599185368 @default.
• W2916787029 cites W1608076165 @default.
• W2916787029 cites W1617328014 @default.
• W2916787029 cites W1883327241 @default.
• W2916787029 cites W1902657069 @default.
• W2916787029 cites W1940277625 @default.
• W2916787029 cites W1981865987 @default.
• W2916787029 cites W2006029213 @default.
• W2916787029 cites W2006602836 @default.
• W2916787029 cites W2008574207 @default.
• W2916787029 cites W2010699829 @default.
• W2916787029 cites W2014318701 @default.
• W2916787029 cites W2017469361 @default.
• W2916787029 cites W2024289681 @default.
• W2916787029 cites W2035613798 @default.
• W2916787029 cites W2073115649 @default.
• W2916787029 cites W2082369656 @default.
• W2916787029 cites W2093138510 @default.
• W2916787029 cites W2109051507 @default.
• W2916787029 cites W2111515114 @default.
• W2916787029 cites W2113144077 @default.
• W2916787029 cites W2121796373 @default.
• W2916787029 cites W2129165537 @default.
• W2916787029 cites W2129821518 @default.
• W2916787029 cites W2132652623 @default.
• W2916787029 cites W2150529573 @default.
• W2916787029 cites W2161374186 @default.
• W2916787029 cites W2164586769 @default.
• W2916787029 cites W2214861484 @default.
• W2916787029 cites W2289189593 @default.
• W2916787029 cites W2298227553 @default.
• W2916787029 cites W2298944450 @default.
• W2916787029 cites W2323108341 @default.
• W2916787029 cites W2337872893 @default.
• W2916787029 cites W2398998624 @default.
• W2916787029 cites W2414592534 @default.
• W2916787029 cites W2416061215 @default.
• W2916787029 cites W2495235786 @default.
• W2916787029 cites W2527038934 @default.
• W2916787029 cites W2765284625 @default.
• W2916787029 cites W2765410674 @default.
• W2916787029 cites W2770301977 @default.
• W2916787029 cites W4251683523 @default.
• W2916787029 doi "https://doi.org/10.3389/fphar.2019.00096" @default.
• W2916787029 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6395447" @default.
• W2916787029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30853910" @default.
• W2916787029 hasPublicationYear "2019" @default.
• W2916787029 type Work @default.
• W2916787029 sameAs 2916787029 @default.
• W2916787029 citedByCount "7" @default.
• W2916787029 countsByYear W29167870292021 @default.
• W2916787029 countsByYear W29167870292022 @default.
• W2916787029 countsByYear W29167870292023 @default.
• W2916787029 crossrefType "journal-article" @default.
• W2916787029 hasAuthorship W2916787029A5005368388 @default.
• W2916787029 hasAuthorship W2916787029A5046904449 @default.
• W2916787029 hasAuthorship W2916787029A5060184027 @default.
• W2916787029 hasAuthorship W2916787029A5064286400 @default.
• W2916787029 hasAuthorship W2916787029A5066336201 @default.
• W2916787029 hasAuthorship W2916787029A5083278883 @default.
• W2916787029 hasBestOaLocation W29167870291 @default.
• W2916787029 hasConcept C126322002 @default.
• W2916787029 hasConcept C142724271 @default.
• W2916787029 hasConcept C168563851 @default.
• W2916787029 hasConcept C177713679 @default.
• W2916787029 hasConcept C197934379 @default.
• W2916787029 hasConcept C204787440 @default.
• W2916787029 hasConcept C27081682 @default.
• W2916787029 hasConcept C2776478404 @default.
• W2916787029 hasConcept C2780580376 @default.
• W2916787029 hasConcept C2780852908 @default.
• W2916787029 hasConcept C535046627 @default.
• W2916787029 hasConcept C71924100 @default.
• W2916787029 hasConceptScore W2916787029C126322002 @default.
• W2916787029 hasConceptScore W2916787029C142724271 @default.
• W2916787029 hasConceptScore W2916787029C168563851 @default.
• W2916787029 hasConceptScore W2916787029C177713679 @default.
• W2916787029 hasConceptScore W2916787029C197934379 @default.
• W2916787029 hasConceptScore W2916787029C204787440 @default.
• W2916787029 hasConceptScore W2916787029C27081682 @default.
• W2916787029 hasConceptScore W2916787029C2776478404 @default.
• W2916787029 hasConceptScore W2916787029C2780580376 @default.
• W2916787029 hasConceptScore W2916787029C2780852908 @default.
• W2916787029 hasConceptScore W2916787029C535046627 @default.

• next